NasdaqGS:MDGLBiotechs
Paulson Trims Madrigal Stake As Equity Grants Highlight Valuation Gap
John Paulson recently made a large reduction in his stake in Madrigal Pharmaceuticals, while the position still remains his largest holding.
Madrigal Pharmaceuticals has approved significant equity inducement awards for new employees as part of recent hiring activity.
These developments come as shares of NasdaqGS:MDGL last closed at $487.32.
Madrigal Pharmaceuticals, trading under NasdaqGS:MDGL, is drawing attention as a major shareholder reshuffles exposure, while the stock trades at...